A Senate panel advanced key legislation that would prevent brand name drug companies from blocking access to much cheaper generic drugs.
The Senate Judiciary Committee voted 16-5 on Thursday to advance the CREATES Act to the Senate floor. The bill would make it easier for generic drug makers to sue brand name drug makers that prevent access to samples of a product of which they want to make a cheaper generic version.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.